| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/25/2008 | US7348359 Retinoid X receptor modulators |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | US7348319 amination of imidate bounded to (bio)polymer, aminoacid, or drug; reactions avoid direct contact with nitric oxide; substrate is medical device: stent, catheter, wound dressing, prosthesis, implant; restenosis, hypotensive agent, and impotency |
| 03/25/2008 | US7348314 Double-stranded ribonucleic acid |
| 03/25/2008 | US7348313 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis |
| 03/25/2008 | US7348312 Polyethylene glycol-albumin colloid that reduces the risk of organ injury and treats hypovolemic conditions by restoring vascular volumes; treating multiorgan dysfunction (MODS), related to systemic inflammatory response syndrome (SIRS); pegylated albumin has an extended useful half-life |
| 03/25/2008 | US7348311 Derivatives of dehydrodidemnin B |
| 03/25/2008 | US7348310 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 03/25/2008 | US7348309 glycosylating an aglycone by combining thymidine or uridine nucleotide diphosphosugars of given structure and a glycosyltransferase; generation of random nucleotide sugar libraries and drug derivatives; treating bacterial infection |
| 03/25/2008 | US7348308 Polypeptides biodrugs with given amino acid sequence which includes phosphorylated serine or threonine; Type II Diabetes and Alzheimer's Disease |
| 03/25/2008 | US7348307 Treating Non-Hodgkins lymphoma by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 03/25/2008 | US7348306 Peptide with a sequence selected from the group consisting of Ser-Leu-Ile-Gly-Arg-Leu-NH2, and trans-cynnamoyl-Leu-Ile-Gly-Arg-Leu-ornithine-NH2 combined with amastatins for activation of protease activated receptor-2; eye drop solution for contact lenses |
| 03/25/2008 | US7348305 Inhibitor of cardiac tachyarrhythmias |
| 03/25/2008 | US7348177 Expression of HIV polypeptides and production of virus-like particles |
| 03/25/2008 | US7348173 Fatty-acid amide hydrolase |
| 03/25/2008 | US7348169 Method of making bioactive catalytic material |
| 03/25/2008 | US7348162 Nucleotide sequences coding polypeptides for use in the treatment and prevention of hematopoietic disorders, osteoporosis, osteogenesis, paget's disease, periodontal disease, hypercalcemia, cancer, cachexia, and |
| 03/25/2008 | US7348155 Method for identifying compounds for treating aging processes in the coronary circulatory system |
| 03/25/2008 | US7348149 Methods of diagnosing Parkinson's disease by measuring expression level of RNA encoding human protein HLLRCR-1 |
| 03/25/2008 | US7348138 Diagnostic methods and kits for identifying individuals exposed to West Nile virus or other viruses including Flavivirus or Pestivirus |
| 03/25/2008 | US7348015 Antigen modified cancer cell vaccines for cancer therapy |
| 03/25/2008 | US7348009 Recombinant allergen with reduced enzymatic activity |
| 03/25/2008 | US7348008 Ricin-like toxins for treatment of cancer |
| 03/25/2008 | US7348007 Mage C2 antigenic peptides and uses thereof |
| 03/25/2008 | US7348005 Administering type V collagen |
| 03/25/2008 | US7348002 peptides and monoclonal antibodies used as blocking agents, that disrupt the interaction between collagen and integrins; prophylaxis of inflammatory diseases |
| 03/25/2008 | US7348000 Therapeutic compositions and methods of treating glycolipid storage related disorders |
| 03/25/2008 | US7347999 use in bone marrow transplantation, into bone marrow cavity or into extraskeletal sites, such as the kidney capsule, muscles, liver, abdominal wall; treatment of diseases affecting the stromal microenvironment that controls hematopoiesis |
| 03/25/2008 | US7347996 Avian cytokines, such as IL-12, comprising a p40 and/or p35 subunit and vaccines |
| 03/25/2008 | US7347995 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients |
| 03/25/2008 | CA2419077C A method of treating a systemic disease |
| 03/25/2008 | CA2385533C Polymer stabilized neuropeptides |
| 03/25/2008 | CA2333145C Drug delivery system comprising a homeobox peptide and a non-peptide, non-nucleotide drug |
| 03/25/2008 | CA2327522C Incorporation of active substances in carrier matrixes |
| 03/25/2008 | CA2243578C High affinity nucleic acid ligands of complement system proteins |
| 03/25/2008 | CA2217679C Peptides and therapeutic agent for autoimmune diseases containing the same |
| 03/25/2008 | CA2189984C P75 tnf receptor promoters |
| 03/25/2008 | CA2115579C Ryegrass pollen allergen |
| 03/25/2008 | CA2073500C Compositions and methods for detecting and modulating rna activity and gene expression |
| 03/25/2008 | CA1341569C Microbial production of human fibroblast interferon |
| 03/20/2008 | WO2008034138A1 Methods and compositions for the topical oxygenation of hypoxic tissue |
| 03/20/2008 | WO2008034133A2 Effect of tula on hiv |
| 03/20/2008 | WO2008034117A2 Methods for using soy peptides to inhibit h3 acetylation, reduce expression of hmg-coa reductase and increase ldl receptor and sp1 expression in a mammal |
| 03/20/2008 | WO2008034116A2 Products and methods using soy peptides to lower total and ldl cholesterol levels |
| 03/20/2008 | WO2008034093A2 HIGHLY FLUORINATED β-AMINO ACIDS AND METHODS OF MAKING AND USING SAME |
| 03/20/2008 | WO2008033987A2 Compositions and methods to prevent cancer with cupredoxins |
| 03/20/2008 | WO2008033910A2 Punctum: drug delivery site for therapeutic peptides and proteins |
| 03/20/2008 | WO2008033890A2 Compositions containing alpha-1-antitrypsin and methods for use |
| 03/20/2008 | WO2008033888A2 Methods for administering long-lasting hypoglycemic agents |
| 03/20/2008 | WO2008033866A2 Methods and compositions for the use of lysine riboswitches |
| 03/20/2008 | WO2008033847A2 Modified protein polymers |
| 03/20/2008 | WO2008033820A2 Modifications of cupredoxin derived peptides and methods of use thereof |
| 03/20/2008 | WO2008033557A2 Click chemistry-derived cyclic peptidomimetics as integrin markers |
| 03/20/2008 | WO2008033518A2 Undercarboxylated/uncarboxylated osteocalcin increases beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decreases fat mass |
| 03/20/2008 | WO2008033499A2 Modulation of regulatory t cells by human il-18 |
| 03/20/2008 | WO2008033488A2 Polypeptides for bone mineralization |
| 03/20/2008 | WO2008033475A2 Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions |
| 03/20/2008 | WO2008033417A2 Methods and compositions for sealing and adhering biological tissues and medical uses thereof |
| 03/20/2008 | WO2008033413A2 Albumin fusion proteins |
| 03/20/2008 | WO2008033374A2 Ocl-2a3 compositions and uses thereof |
| 03/20/2008 | WO2008033119A1 Novel combinations of dnak inhibitors with known antibacterial agents |
| 03/20/2008 | WO2008033106A1 Binding domain of plasmodium reticulocyte binding proteins |
| 03/20/2008 | WO2008033058A2 Method for producing insulin in the form of an oral preparation |
| 03/20/2008 | WO2008033044A1 A method and preparations for the diagnosis and therapy of multiple sclerosis and immune demyelinating polyneuropathy |
| 03/20/2008 | WO2008032847A1 External preparation for skin |
| 03/20/2008 | WO2008032783A1 Artificial antibacterial peptide and use thereof |
| 03/20/2008 | WO2008032777A1 Antibacterial peptide and use thereof |
| 03/20/2008 | WO2008032695A1 A/d converter and a/d converting method |
| 03/20/2008 | WO2008032694A1 A/d converter and a/d converting method |
| 03/20/2008 | WO2008032607A1 A/d converter, a/d converting method, a/d converting program and control apparatus |
| 03/20/2008 | WO2008032450A1 Prophylactic and/or therapeutic agent for fatty liver |
| 03/20/2008 | WO2008032432A1 Gel type enteric nutrient |
| 03/20/2008 | WO2008032153A2 Calreticulin for its use as a medication for the treatment of cancer in a mammal |
| 03/20/2008 | WO2008032093A1 Cancer treatment |
| 03/20/2008 | WO2008032073A2 Novel nematode protein and its use in producing anthelminthic agents and vaccines |
| 03/20/2008 | WO2008032059A2 Growth factor |
| 03/20/2008 | WO2008032054A2 Composite material comprising a tissue matrix compound and a bioactive glass |
| 03/20/2008 | WO2008031331A1 A recombinant adenovirus target-oriented coexpressing human p53 and p53aip1 |
| 03/20/2008 | WO2008031233A1 Compositions and methods for treatment of chronic fatigue syndrome and neurodegenerative diseases |
| 03/20/2008 | WO2008031182A1 Process for synthesis and incorporation of nitric oxide donors in macromolecular compositions |
| 03/20/2008 | WO2008031172A1 Methods and compositions for promoting organ development |
| 03/20/2008 | WO2008018111A3 Composition containing cranberry (vaccinium macrocarpon) and lactoferrin for the prevention and treatment of urinary tract infections |
| 03/20/2008 | WO2008018103B1 Product, suitable to be given to the human body for its protective effects and health benefits, based on cow buffalo's milk self-enriched with lactoferrin, or pure lactoferrin, obtained through membrane separative processes |
| 03/20/2008 | WO2008015344A3 Dermatological and/or cosmetic composition containing polypeptides or peptides of the protein slc24a5 |
| 03/20/2008 | WO2008010840A3 Fsh mutants |
| 03/20/2008 | WO2008006103A3 Nogo receptor functional motifs, peptide mimetics, and mutated functional motifs related thereto, and methods of using the same |
| 03/20/2008 | WO2008001196A3 Contraceptive medicine comprising luteinizing hormone |
| 03/20/2008 | WO2007149861A3 Soft tissue repair and regeneration using stem cell products |
| 03/20/2008 | WO2007141043A3 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma |
| 03/20/2008 | WO2007140505A3 Vaccine carrier |
| 03/20/2008 | WO2007140471A3 Ribosome and rna display of biologically active small molecules |
| 03/20/2008 | WO2007140358A3 Treatment of polyglutamine-expansion neurodegenerative diseases |
| 03/20/2008 | WO2007137591A3 Hiv vaccine |
| 03/20/2008 | WO2007137015A3 Dermatological uses of tri-, tetra-, penta-, and polypeptides |
| 03/20/2008 | WO2007135117A3 Soluble, stable insulin-containing formulations |
| 03/20/2008 | WO2007133571A3 Methods and compositions related to tr4 |
| 03/20/2008 | WO2007130453A3 Non-natural amino acid substituted polypeptides |
| 03/20/2008 | WO2007113784A3 Methods for modulating the levels and effects of thyrotropin-releasing hormone (trh) and trh-related petides |
| 03/20/2008 | WO2007103739A3 Methods and compositions related to cyclic peptide synthesis |
| 03/20/2008 | WO2007100535A3 Oxyntomodulin derivatives |